Is Bright Minds Biosciences Inc. (DRUG) a Buy, Sell, or Hold?
NASDAQ : DRUG
Bright Minds Biosciences Inc. — Institutional Ownership
$80 USD
$2.65 (3.43%)
- Volume
- 115.53K
- Average Volume
- 253.81K
- Market Capitalization
- $782.97M
- P/E Ratio
- -32.32
- Dividend Yield
- 0.00%
- Price Target
- $145.00
- Year High
- $123.75
- Year Low
- $33.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $81.48
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-02 | Ian McDonald | 1.4M | 13.70% |
| 2026-05-15 | Vestal Point Capital, LP | 492.32K | 5.00% |
| 2026-05-15 | JANUS HENDERSON GROUP PLC | 1.28M | 13.10% |
| 2026-05-15 | JANUS HENDERSON GROUP PLC | 1.28M | 13.10% |
| 2026-05-12 | Vivo Opportunity Fund Holdings, L.P. | 504.64K | 5.20% |
| 2026-04-30 | Cormorant Asset Management, LP | 950K | 9.71% |
| 2026-02-17 | Perceptive Advisors LLC | 449.29K | 4.60% |
| 2026-02-17 | JANUS HENDERSON GROUP PLC | 1.16M | 14.90% |
| 2026-02-17 | Commodore Capital LP | 18851.0 | 0.30% |
| 2026-02-06 | Cormorant Asset Management, LP | 1.06M | 10.88% |
| 2025-11-14 | Vivo Opportunity Fund Holdings, L.P. | 454.18K | 6.40% |
| 2025-11-13 | Adage Capital Management, L.P. | 395.74K | 5.58% |
| 2025-11-12 | Sio Capital Management, LLC | 190.76K | 2.69% |
| 2025-08-14 | JANUS HENDERSON GROUP PLC | 1.15M | 16.30% |
| 2025-08-13 | Sio Capital Management, LLC | 512.34K | 7.27% |
| 2025-05-15 | RA Capital Management, L.P. | 206.43K | 2.90% |
| 2025-05-15 | Perceptive Advisors LLC | 444.65K | 6.30% |
| 2025-04-08 | Sio Capital Management, LLC | 507.56K | 7.21% |
| 2025-04-07 | JANUS HENDERSON GROUP PLC | 1.11M | 16.00% |
| 2025-02-14 | Point72 Asset Management, L.P. | 135.19K | 3.00% |
| 2025-02-14 | COMMODORE CAPITAL LP | 500K | 7.20% |
| 2025-02-10 | Sio Capital Management, LLC | 451.79K | 6.50% |
| 2025-02-07 | JANUS HENDERSON GROUP PLC | 804.98K | 11.60% |
| 2024-11-12 | RA Capital Healthcare Fund, L.P. | 460.83K | 6.60% |
| 2024-11-12 | Peter Kolchinsky | 460.83K | 6.60% |
| 2024-11-12 | Rajeev Shah | 460.83K | 6.60% |
| 2024-11-12 | RA Capital Management, L.P. | 460.83K | 6.60% |
| 2024-10-25 | Capital LP | 400K | 9.00% |
| 2024-10-25 | Capital Master LP | 400K | 9.00% |
| 2024-10-23 | Arsani William | 100000.0 | 11.00% |
| 2024-10-23 | Logos GP LLC | 100000.0 | 11.00% |
| 2024-10-23 | Point72 Asset Management, L.P. | 435K | 9.70% |
| 2024-10-23 | Point72 Capital Advisors, Inc. | 435K | 9.70% |
| 2024-10-23 | Steven A. Cohen | 435K | 9.70% |
| 2024-10-23 | Logos Global Management LP | 100000.0 | 11.00% |
| 2024-10-23 | Logos Global Management GP LLC | 100000.0 | 11.00% |
| 2024-10-23 | Logos Global Master Fund LP | 100000.0 | 11.00% |
| 2024-10-22 | Cormorant Global Healthcare GP, LLC | 850K | 18.79% |
| 2024-10-22 | Cormorant Global Healthcare Master Fund, LP | 850K | 18.79% |
| 2024-10-22 | Cormorant Asset Management, LP | 850K | 18.79% |
| 2024-10-22 | Bihua Chen | 850K | 18.79% |
| 2024-10-16 | Joseph Edelman | 430K | 9.60% |
| 2024-10-16 | Perceptive Advisors LLC | 430K | 9.60% |
| 2024-10-16 | Perceptive Life Sciences Master Fund, Ltd. | 430K | 9.60% |
| 2024-01-18 | Ian McDonald | 179.08K | 7.57% |
DRUG Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-09-30 | $84.44 | 6.88M | $580.75M | $82.91M | $125.78K | $497.97M |
| 2024-09-30 | $1.58 | 4.31M | $6.82M | $5.72M | $118.96K | $1.22M |
| 2023-09-30 | $2.17 | 3.72M | $8.08M | $6.75M | $73549 | $1.4M |
| 2022-09-30 | $8.50 | 2.47M | $21.01M | $11.63M | $139.91K | $9.52M |
| 2021-09-30 | $45.26 | 1.79M | $81.24M | $19.76M | -$ | $61.48M |
| 2020-09-30 | $35.95 | 1.28M | $46.05M | $799.93K | -$ | $45.25M |
| 2019-09-30 | $35.75 | 1.28M | $45.78M | $79991 | -$ | $45.7M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $101.53 | 9.59M | $973.7M | $309.3M | $82071 | $664.48M |
| 2025-12-31 | $107.08 | 7.76M | $831.06M | $89.05M | $104.9K | $742.11M |
| 2025-09-30 | $84.44 | 7.17M | $605.21M | $82.91M | $125.78K | $522.42M |
| 2025-06-30 | $35.51 | 7.08M | $251.57M | $51.39M | $141.03K | $200.33M |
| 2025-03-31 | $51.89 | 4.46M | $231.59M | $55.68M | $166.6K | $176.07M |
| 2024-12-31 | $51.80 | 4.46M | $231.18M | $57.9M | $182.73K | $173.47M |
| 2024-09-30 | $1.58 | 4.46M | $7.06M | $5.72M | $118.96K | $1.46M |
| 2024-06-30 | $1.44 | 4.46M | $6.41M | $6.19M | $14016 | $231K |
| 2024-03-31 | $1.87 | 4.46M | $8.33M | $5.93M | $34732 | $2.43M |
| 2023-12-31 | $1.89 | 3.84M | $7.27M | $6.76M | $54563 | $567.9K |
| 2023-09-30 | $2.17 | 3.77M | $8.19M | $6.75M | $73549 | $1.52M |
| 2023-06-30 | $3.77 | 3.77M | $14.23M | $8.13M | $91408 | $6.2M |